Dermal fibroblast proliferation

Dermal fibroblast proliferation refers to the expansion of fibroblast numbers within the dermis, a key component of skin development, homeostasis, and the proliferative phase of wound healing. Dermal fibroblasts synthesize and remodel extracellular matrix (collagens, elastin, fibronectin), migrate into wound beds, and can differentiate into myofibroblasts; their proliferation is regulated by growth factors such as PDGF, TGF-β, VEGF, and bFGF, and by ECM feedback mechanisms. Experimental studies show PDGF-BB is a potent mitogen/motogen for human dermal fibroblasts, increasing migration and ECM production, while innate immune signals (e.g., LPS) can trigger proliferation via p38/MAPK and stathmin-mediated microtubule dynamics; antimicrobial peptides such as human neutrophil peptides can also increase fibroblast proliferation measured by Ki-67 and cell growth assays. Although necessary for repair, dysregulated proliferation/activation contributes to fibrosis and scarring and is implicated in inflammatory and autoimmune skin diseases.

Other names

Fibroblast proliferation (dermis)Human dermal fibroblast proliferation (HDF proliferation)

Growth factor stimulation of fibroblast proliferation and migration via PDGF signaling pathways (PDGF-BB acts as mitogen/motogen; enhances ECM protein production) TGF-β signaling promoting myofibroblast differentiation and matrix deposition (wound healing context) p38/MAPK activation driving proliferation in response to stimuli such as lipopolysaccharide via stathmin-mediated microtubule depolymerization